Circadian Rhythm Sleep Treatment Market
Circadian Rhythm Sleep Treatment Market Study by Devices, Medications, and Chronotherapy from 2024 to 2034
Analysis of Circadian Rhythm Sleep Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Circadian Rhythm Sleep Treatment Market Outlook (2024 to 2034)
The global circadian rhythm sleep treatment market size is estimated at US$ 784.7 million in 2024 and is projected to reach a size of US$ 1.23 billion by the end of 2034, expanding at a CAGR of 4.7% between 2024 and 2034.
Circadian rhythm sleep disruption is the term used to describe a disturbance in sleep patterns that impacts the body's fundamental processes. Restlessness, extreme tiredness, and sleeplessness are a few signs of this sleep condition.
Circadian rhythms, which are commonly referred to as the biological clock, regulate various daily functions such as body temperature, attentiveness, hormone release, and sleep patterns.
When an individual's circadian rhythm is not in harmony with their environment, they experience difficulty falling asleep, which affects their quality of sleep. If the sleep-wake cycle is disturbed to the point where it interferes with daily activities, then it is termed a circadian rhythm disruption. Any changes to the suprachiasmatic nucleus region cause memory loss or sleeplessness. In addition, delayed sleep phase disorder is a circadian rhythm sleep condition linked to problems falling asleep, wherein, the sleep event begins later than intended.
Several illnesses have been linked to disturbances in the circadian rhythm. Urbanization and industrialization have collectively increased the risk of chronic diseases among corporate workers.
| Report Attributes | Details |
|---|---|
| Circadian Rhythm Sleep Treatment Market Size (2024E) | US$ 784.7 Million |
| Forecasted Market Value (2034F) | US$ 1.23 Billion |
| Global Market Growth Rate (2024 to 2034) | 4.7% CAGR |
| North America Market Share (2034F) | 35.6% |
| East Asia Market Growth Rate (2024 to 2034) | 5.6% CAGR |
| Institutional Segment Market Share (2024E) | 78.8% |
| Delayed Sleep Phase Syndrome Segment Market Share (2024E) | 50.7% |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What are the Factors Driving Global Circadian Rhythm Sleep Treatment Market Expansion?
“Focus on Addressing Interplay Between Depression and Insomnia and Consequent Financial Impact”
Due to the severe burden illnesses related to circadian rhythm disruption place on society overall, including high rates of morbidity and mortality as well as financial consequences, society is forced to depend more on treatments for sleep disorders, which is driving the global circadian rhythm sleep treatment market growth.
- According to the World Health Organization (WHO), depression is a widespread illness that impacts more than 264 million individuals and eventually results in sleep disturbances or other significant health issues. The prevalence of depression is one of the primary drivers in the market for sleep disorders.
An increasing amount of data, mostly from Western countries, shows that the average length of sleep is decreasing and that the prevalence of insomnia is rising. More than 20% of people have insomnia, according to national surveys done in the United States and Canada. This percentage is consistent with the frequent occurrence of short sleep duration in developed countries.
“Public Health Initiatives Promoting Awareness about Circadian Rhythm Sleep Disorders”
The rising awareness of circadian rhythm sleep disorders can be attributed to increased public health initiatives, education campaigns, and the dissemination of information through digital platforms. Increasing knowledge and symptoms of CRSDs among patients and medical professionals is another factor contributing to the rise in diagnosis rates. As diagnosis becomes more readily available, more people are looking for appropriate treatment and management alternatives, which is driving market expansion.
Increased emphasis on diagnosis and awareness is drawing funding for research and development, opening the door for cutting-edge technologies and treatment approaches. As a result, improved healthcare practices and a greater comprehension of the relationship between heart health and sleep are driving market growth.
What are the Issues Related to Circadian Rhythm Sleep Treatment?
“Limited Awareness about Circadian Rhythm Sleep Disorders Entailing Misdiagnosis”
The lack of understanding about sleep disorders associated with the circadian rhythm is a significant obstacle to market growth. It is possible that neither the general public nor medical professionals are aware of the symptoms or that they are mistaken for other ailments. Furthermore, this misinformation could lead to delayed treatment and an inaccurate diagnosis, which is expected to hinder market growth.
Limited awareness affects many aspects of the market, including difficulties in obtaining funds for research and development in this domain and misdiagnosis. Patients often do not know about the possible hazards of sleep gummies or the availability of efficient treatment choices, which reduces demand for existing therapies and impedes market expansion.
Closing the knowledge gap is essential for stimulating innovation in treatments that combine sleep aid supplements and cardiology, as well as for enhancing patient outcomes and market growth.
“High Treatment Cost and Safety Concerns over Circadian Rhythm Lighting”
Adoption of treatments such as circadian rhythm lighting is projected to be hindered by elevated costs and increasing concerns about potential negative effects on eyesight. Industry players encounter challenges stemming from limited research and uncertainties regarding impulsive behavior and weight gain linked to prolonged use of circadian rhythm lighting.
Specific dangers and considerations are tied to the application of circadian rhythm lighting as a therapeutic approach in circadian rhythm sleep treatment. Despite the intention of this innovative strategy to regulate the body's internal clock and possibly improve cardiac health and sleep quality, careful attention must be given to address potential hazards and hurdles.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
Throughout the forecast period, North America is projected to hold a major revenue share and lead the worldwide market. The aging population's growing need, technological advancements, and a healthcare system that focuses on addressing cardiac diseases connected to sleep effectively are driving the growth of the circadian rhythm sleep treatment market.
What’s Consolidating the Position of the United States on the Global Platform?
“Robust Healthcare Infrastructure and Technological Advancements in Therapy”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 238 Million |
| Growth Rate (2024 to 2034) | 5% CAGR |
| Projected Value (2034F) | US$ 389 Million |
Growing number of mental health issues resulting from sleep disorders in the country, coupled with the improved healthcare infrastructure and awareness of the detrimental impacts of sleep disorders, is driving market expansion.
The United States market is growing quickly as a result of increased awareness and sophisticated healthcare systems. Demand for circadian rhythm sleep treatment is being driven by factors such as changes in lifestyle, a rise in the prevalence of sleep disorders, and greater awareness of the effects of circadian rhythms on general health. The market is growing because of innovations in therapy, such as wearable technology and light-based treatments.
Why is the Market in Japan Expanding Steadily?
“Healthcare Policies Prioritizing Sleep Disorder Management amid Increase in Stress Levels”
| Attribute | Japan |
|---|---|
| Market Value (2024E) | US$ 60 Million |
| Growth Rate (2024 to 2034) | 4.8% CAGR |
| Projected Value (2034F) | US$ 96 Million |
The circadian rhythm sleep treatment market size in Japan is driven by the awareness of the significance of sleep health and its relationship to cardiovascular health. The management of sleep disorders associated with heart health is becoming an integral part of preventive care, with government policies and healthcare programs increasingly incorporating such measures.
Sleep disorders are worsened by the work culture and lifestyle in Japan, which are characterized by lengthy workdays and high levels of stress. The necessity for efficient circadian rhythm sleep therapies is fueled by this social factor.
The market in Japan is transforming due to certain cultural, demographic, and medical system aspects. With its increasingly aging population and sophisticated healthcare system, Japan offers opportunities as well as challenges in this specialized medical field.
Category-wise Insights
The introduction of circadian rhythm sleep treatment devices into the market signifies a fusion of advanced technology and robust healthcare infrastructure, providing novel, non-invasive treatment options that are simple to incorporate into everyday life. A significantly delayed sleep-wake cycle is the symptom of delayed sleep phase syndrome (DSPS), a circadian rhythm sleep disorder.
Which Treatment Accounts for Significant Revenue Streams?
“Device-based Therapies Becoming Popular as Technology-driven Approach for Treating Sleep Disorders”
| Attribute | Devices |
|---|---|
| Segment Value (2024E) | US$ 528.3 Million |
| Growth Rate (2024 to 2034) | 4.6% CAGR |
| Projected Value (2034F) | US$ 831.6 Billion |
Adoption of device-based therapies is a major circadian rhythm sleep treatment market trend, which represents a big change towards cutting-edge, tech-driven approaches to treating sleep problems. Sleep masks are becoming essential instruments in the treatment of a variety of sleep-related problems since they are made to realign and support the body's natural circadian cycles.
The elements produce light that replicates sunlight, which aids in resetting the body's circadian clock. They are especially helpful for diseases like SAD (seasonal affective disorder) and other depressions associated with irregularities in the circadian cycle.
Sleep aid devices that track sleep patterns and offer insights into the sleep-wake cycle include fitness trackers and smartwatches. Even features to gently urge a return to regular sleep patterns are included in some more advanced models.
Which Disorder Segment Accounts for a Leading Market Share?
"High Demand for Treatment Targeting Delayed Sleep-Wake Phase Disorder”
| Attribute | Delayed Sleep Phase Syndrome |
|---|---|
| Segment Value (2024E) | US$ 397.5 Million |
| Growth Rate (2024 to 2034) | 5.1% CAGR |
| Projected Value (2034F) | US$ 650.6 Billion |
Due to neuron dysfunction in older adults, teenagers, and comorbidities, the delayed sleep-wake phase syndrome segment holds a significant circadian rhythm sleep treatment market share in 2024. A person experiencing delayed sleep-wake phase disorder (DSWPD) typically goes to bed two or more hours later than what is considered normal or socially acceptable. The inability to fall asleep at the intended hour is the root of this issue. One common complaint among the elderly is lack of sleep.
- In a National Institute on Aging survey of more than 9,000 adults 65 years of age and older, more than half of the men and women reported having at least one ongoing sleep problem.
The younger generation's sleep problems can show up in many different ways, such as difficulty falling and staying asleep.
- The National Library of Medicine reports that the most common circadian rhythm sleep issue, contributing to the segment's rise, is delayed sleep phase disorder, which affects 0.17% of adults in the United States and 7% to 16% percent of adolescents.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
To satisfy more customers, industry leaders are bringing new and inventive items to the market. To increase their consumer base and strengthen their market position, multinational corporations are expanding into new markets in developing countries.
- Japanese pharmaceutical company Eisai Co. announced in December 2019 that the United States Food and Drug Administration authorized Dayvigo, a drug for adult patients suffering from insomnia. Based on two late-stage trials comparing Dayvigo to placebo for up to one month and six months in patients with insomnia, the FDA approved the drug in dosages of 5 mg and 10 mg.
Segmentation of Circadian Rhythm Sleep Treatment Market Research
-
By Treatment :
- Devices
- Medications
- Chronotherapy
-
By Disorder :
- Delayed Sleep Phase Syndrome
- Advanced Sleep Phase Syndrome
- Non-24-hour Sleep-wake Syndrome
- Irregular Sleep-wake Disorders
- Shift Work Disorders
- Jet Lag
-
By Sales Channel :
- Institutional Sales
- Retail Sales
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
1. Global Market - Executive Summary 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and Recommendations 2. Global Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Impact Benchmark with Previous Crisis 3.1.1.1. Change in Demand 3.1.1.2. Before and After COVID-19 Crisis (Projected) 3.1.1.3. Before and After Sub-prime Crisis – 2008 (Actual) 3.1.1.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.2. Impact on Market and Value (US$ Mn) 3.1.2.1. Likely Loss of Value in 2023 3.1.2.2. Mid-term and Long-term Forecasts 3.1.2.3. Quarter by Quarter Demand and Recovery Assessment 3.1.3. Anticipated Demand and Value Recovery Curve 3.1.3.1. Likelihood of U-Shape Recovery 3.1.3.2. Likelihood of L-Shape Recovery 3.1.4. Recovery Period Assessment by Key Countries 3.1.5. Recovery Assessment by Key Market Segments 3.1.6. Action Points and Recommendations for Suppliers 3.1.7. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Treatment Development Trends 4. Market Background and Foundation Data Points 4.1. Need of the Hour for Industries 4.2. Industry Wise Industry 4.0 4.3. Strategic Priorities 4.4. Life Cycle Stage 4.5. Importance of Technology 4.6. Use Cases of Circadian Rhythm Sleep Treatment 4.7. Forecast Factors: Relevance and Impact 4.8. Investment Feasibility Matrix 4.9. PESTLE Analysis 4.10. Porter’s Five Forces Analysis 4.11. Market Dynamics 4.11.1. Drivers 4.11.2. Restraints 4.11.3. Opportunity Analysis 4.11.4. Trend 5. Global Market Demand (US$ Mn) Analysis 2018 to 2023 and Forecast, 2024 to 2034 5.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2023 5.2. Current and Future Market Value (US$ Mn) Projections, 2024 to 2034 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Treatment 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Mn) Analysis By Treatment, 2018 to 2023 6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Treatment, 2024 to 2034 6.3.1. Devices 6.3.2. Medications 6.3.3. Chronotherapy 6.4. Market Attractiveness Analysis By Treatment 7. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Disorder 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Mn) Analysis By Disorder, 2018 to 2023 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Disorder, 2024 to 2034 7.3.1. Delayed Sleep Phase Syndrome 7.3.2. Advanced Sleep Phase Syndrome 7.3.3. Non-24-hour Sleep-wake Syndrome 7.3.4. Irregular Sleep-wake Disorders 7.3.5. Shift Work Disorders 7.3.6. Jet Lag 7.4. Market Attractiveness Analysis By Disorder 8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Sales Channel 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Mn) Analysis By Sales Channel, 2018 to 2023 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Sales Channel, 2024 to 2034 8.3.1. Institutional Sales 8.3.2. Retail Sales 8.4. Market Attractiveness Analysis By Sales Channel 9. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018 to 2023 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 10.3.1. By Country 10.3.1.1. United States 10.3.1.2. Canada 10.3.2. By Treatment 10.3.3. By Disorder 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Treatment 10.4.3. By Disorder 11. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Treatment 11.3.3. By Disorder 11.3.4. By Sales Channel 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Treatment 11.4.3. By Disorder 11.4.4. By Sales Channel 12. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. United Kingdom 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Treatment 12.3.3. By Disorder 12.3.4. By Sales Channel 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Treatment 12.4.3. By Disorder 12.4.4. By Sales Channel 13. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Treatment 13.3.3. By Disorder 13.3.4. By Sales Channel 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Treatment 13.4.3. By Disorder 13.4.4. By Sales Channel 14. South Asia & Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. ANZ 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Treatment 14.3.3. By Disorder 14.3.4. By Sales Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Treatment 14.4.3. By Disorder 14.4.4. By Sales Channel 15. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Treatment 15.3.3. By Disorder 15.3.4. By Sales Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Treatment 15.4.3. By Disorder 15.4.4. By Sales Channel 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. Vanda Pharmaceuticals, Inc. 17.3.1.1. Company Overview 17.3.1.2. Treatment overview 17.3.1.3. SWOT Analysis 17.3.1.4. Key Developments 17.3.2. Akeda Pharmaceutical Company Limited 17.3.2.1. Company Overview 17.3.2.2. Treatment overview 17.3.2.3. SWOT Analysis 17.3.2.4. Key Developments 17.3.3. Idorsia Pharmaceuticals Ltd. 17.3.3.1. Company Overview 17.3.3.2. Treatment overview 17.3.3.3. SWOT Analysis 17.3.3.4. Key Developments 17.3.4. VU University Medical Center 17.3.4.1. Company Overview 17.3.4.2. Treatment overview 17.3.4.3. SWOT Analysis 17.3.4.4. Key Developments 17.3.5. Neuraxpharm 17.3.5.1. Company Overview 17.3.5.2. Treatment overview 17.3.5.3. SWOT Analysis 17.3.5.4. Key Developments 17.3.6. The Sunbox Company 17.3.6.1. Company Overview 17.3.6.2. Treatment overview 17.3.6.3. SWOT Analysis 17.3.6.4. Key Developments 18. Assumptions and Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Treatment, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Disorder, 2018 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Disorder, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Sales Channel, 2018 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Sales Channel, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Sales Channel, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Treatment, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Disorder, 2018 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Disorder, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by Sales Channel, 2018 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by Sales Channel, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Sales Channel, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 28: Latin America Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2023
Table 29: Latin America Market Value (US$ Mn) Analysis, by Treatment, 2024 to 2034
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Disorder, 2018 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Disorder, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by Sales Channel, 2018 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by Sales Channel, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Sales Channel, 2024 to 2034
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Europe Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2023
Table 41: Europe Market Value (US$ Mn) Analysis, by Treatment, 2024 to 2034
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2024 to 2034
Table 43: Europe Market Value (US$ Mn) Analysis, by Disorder, 2018 to 2023
Table 44: Europe Market Value (US$ Mn) Analysis, by Disorder, 2024 to 2034
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2024 to 2034
Table 46: Europe Market Value (US$ Mn) Analysis, by Sales Channel, 2018 to 2023
Table 47: Europe Market Value (US$ Mn) Analysis, by Sales Channel, 2024 to 2034
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by Sales Channel, 2024 to 2034
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 52: East Asia Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2023
Table 53: East Asia Market Value (US$ Mn) Analysis, by Treatment, 2024 to 2034
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2024 to 2034
Table 55: East Asia Market Value (US$ Mn) Analysis, by Disorder, 2018 to 2023
Table 56: East Asia Market Value (US$ Mn) Analysis, by Disorder, 2024 to 2034
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2024 to 2034
Table 58: East Asia Market Value (US$ Mn) Analysis, by Sales Channel, 2018 to 2023
Table 59: East Asia Market Value (US$ Mn) Analysis, by Sales Channel, 2024 to 2034
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by Sales Channel, 2024 to 2034
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2023
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Treatment, 2024 to 2034
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2024 to 2034
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Disorder, 2018 to 2023
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Disorder, 2024 to 2034
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2024 to 2034
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by Sales Channel, 2018 to 2023
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by Sales Channel, 2024 to 2034
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Sales Channel, 2024 to 2034
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: MEA Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2023
Table 77: MEA Market Value (US$ Mn) Analysis, by Treatment, 2024 to 2034
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2024 to 2034
Table 79: MEA Market Value (US$ Mn) Analysis, by Disorder, 2018 to 2023
Table 80: MEA Market Value (US$ Mn) Analysis, by Disorder, 2024 to 2034
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2024 to 2034
Table 82: MEA Market Value (US$ Mn) Analysis, by Sales Channel, 2018 to 2023
Table 83: MEA Market Value (US$ Mn) Analysis, by Sales Channel, 2024 to 2034
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by Sales Channel, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Treatment, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Treatment, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Treatment, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Disorder, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Disorder, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Disorder, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Sales Channel, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Sales Channel, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Sales Channel, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 21: North America Market Share Analysis by Country, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by Treatment, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by Treatment, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Treatment, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Disorder, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Disorder, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Disorder, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by Sales Channel, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by Sales Channel, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by Sales Channel, 2024 to 2034
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 40: Latin America Market Share and BPS Analysis by Treatment, 2024 & 2034
Figure 41: Latin America Market Y-o-Y Growth Projections by Treatment, 2024 to 2034
Figure 42: Latin America Market Attractiveness Analysis by Treatment, 2024 to 2034
Figure 43: Latin America Market Share and BPS Analysis by Disorder, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projections by Disorder, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Disorder, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by Sales Channel, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by Sales Channel, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by Sales Channel, 2024 to 2034
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 52: Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 53: Europe Market Share Analysis by Country, 2024 & 2034
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 55: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 56: Europe Market Share and BPS Analysis by Treatment, 2024 & 2034
Figure 57: Europe Market Y-o-Y Growth Projections by Treatment, 2024 to 2034
Figure 58: Europe Market Attractiveness Analysis by Treatment, 2024 to 2034
Figure 59: Europe Market Share and BPS Analysis by Disorder, 2024 & 2034
Figure 60: Europe Market Y-o-Y Growth Projections by Disorder, 2024 to 2034
Figure 61: Europe Market Attractiveness Analysis by Disorder, 2024 to 2034
Figure 62: Europe Market Share and BPS Analysis by Sales Channel, 2024 & 2034
Figure 63: Europe Market Y-o-Y Growth Projections by Sales Channel, 2024 to 2034
Figure 64: Europe Market Attractiveness Analysis by Sales Channel, 2024 to 2034
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 68: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 69: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 71: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 72: East Asia Market Share and BPS Analysis by Treatment, 2024 & 2034
Figure 73: East Asia Market Y-o-Y Growth Projections by Treatment, 2024 to 2034
Figure 74: East Asia Market Attractiveness Analysis by Treatment, 2024 to 2034
Figure 75: East Asia Market Share and BPS Analysis by Disorder, 2024 & 2034
Figure 76: East Asia Market Y-o-Y Growth Projections by Disorder, 2024 to 2034
Figure 77: East Asia Market Attractiveness Analysis by Disorder, 2024 to 2034
Figure 78: East Asia Market Share and BPS Analysis by Sales Channel, 2024 & 2034
Figure 79: East Asia Market Y-o-Y Growth Projections by Sales Channel, 2024 to 2034
Figure 80: East Asia Market Attractiveness Analysis by Sales Channel, 2024 to 2034
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2024 to 2034
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2024 & 2034
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Treatment, 2024 & 2034
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Treatment, 2024 to 2034
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Treatment, 2024 to 2034
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Disorder, 2024 & 2034
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Disorder, 2024 to 2034
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Disorder, 2024 to 2034
Figure 94: South Asia & Oceania Market Share and BPS Analysis by Sales Channel, 2024 & 2034
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by Sales Channel, 2024 to 2034
Figure 96: South Asia & Oceania Market Attractiveness Analysis by Sales Channel, 2024 to 2034
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 100: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 101: MEA Market Share Analysis by Country, 2024 & 2034
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 103: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 104: MEA Market Share and BPS Analysis by Treatment, 2024 & 2034
Figure 105: MEA Market Y-o-Y Growth Projections by Treatment, 2024 to 2034
Figure 106: MEA Market Attractiveness Analysis by Treatment, 2024 to 2034
Figure 107: MEA Market Share and BPS Analysis by Disorder, 2024 & 2034
Figure 108: MEA Market Y-o-Y Growth Projections by Disorder, 2024 to 2034
Figure 109: MEA Market Attractiveness Analysis by Disorder, 2024 to 2034
Figure 110: MEA Market Share and BPS Analysis by Sales Channel, 2024 & 2034
Figure 111: MEA Market Y-o-Y Growth Projections by Sales Channel, 2024 to 2034
Figure 112: MEA Market Attractiveness Analysis by Sales Channel, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the circadian rhythm sleep treatment market?
The global circadian rhythm sleep treatment market is estimated at US$ 784.7 million in 2024.
What is the projected sales value of the global market for 2034?
By 2034-end, worldwide revenue from circadian rhythm sleep treatment is forecasted to reach US$ 1.23 billion.
At what rate is the demand for circadian rhythm sleep treatments forecasted to increase?
Demand for circadian rhythm sleep treatment is forecasted to rise at 4.7% CAGR over the next 10 years.
How is the market evolving in East Asia?
The market in East Asia is projected to increase at 5.6% CAGR from 2024 to 2034.
Which sales channel-based segment is gaining traction?
Retail sales of circadian rhythm sleep therapies and devices are forecasted to rise at a CAGR of 4.7% from 2024 to 2034.
Circadian Rhythm Sleep Treatment Market